Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neuroimaging | 68 | 2023 | 403 | 15.880 |
Why?
|
Magnetic Resonance Imaging | 185 | 2024 | 7702 | 11.570 |
Why?
|
Brain | 98 | 2023 | 4113 | 10.210 |
Why?
|
Diffusion Tensor Imaging | 36 | 2023 | 303 | 9.680 |
Why?
|
Diffusion Magnetic Resonance Imaging | 37 | 2023 | 341 | 6.940 |
Why?
|
Brain Diseases | 18 | 2021 | 403 | 5.350 |
Why?
|
Hypoxia-Ischemia, Brain | 20 | 2021 | 137 | 5.320 |
Why?
|
Cerebellar Diseases | 19 | 2021 | 89 | 4.430 |
Why?
|
Nervous System Malformations | 10 | 2023 | 133 | 4.380 |
Why?
|
Image Enhancement | 21 | 2018 | 561 | 4.240 |
Why?
|
Cerebellum | 30 | 2023 | 449 | 4.190 |
Why?
|
Prenatal Diagnosis | 24 | 2023 | 590 | 4.110 |
Why?
|
Ultrasonography | 24 | 2021 | 1863 | 3.980 |
Why?
|
Hydrocephalus | 15 | 2024 | 217 | 3.780 |
Why?
|
Craniocerebral Trauma | 10 | 2022 | 130 | 3.580 |
Why?
|
Child | 173 | 2024 | 29154 | 3.230 |
Why?
|
Arnold-Chiari Malformation | 8 | 2024 | 43 | 3.230 |
Why?
|
Tomography, X-Ray Computed | 53 | 2023 | 7551 | 3.060 |
Why?
|
Abnormalities, Multiple | 15 | 2022 | 998 | 3.020 |
Why?
|
Spinal Cord | 11 | 2023 | 690 | 2.980 |
Why?
|
Infant, Newborn | 90 | 2023 | 8223 | 2.940 |
Why?
|
Fetal Diseases | 16 | 2018 | 388 | 2.800 |
Why?
|
Brain Ischemia | 12 | 2023 | 292 | 2.720 |
Why?
|
Brain Stem | 12 | 2022 | 175 | 2.690 |
Why?
|
Brain Injuries | 11 | 2023 | 787 | 2.680 |
Why?
|
Spinal Dysraphism | 5 | 2023 | 265 | 2.620 |
Why?
|
Infant | 103 | 2023 | 13310 | 2.520 |
Why?
|
Child, Preschool | 107 | 2024 | 16273 | 2.450 |
Why?
|
Kidney Diseases, Cystic | 8 | 2023 | 61 | 2.340 |
Why?
|
Spinal Cord Neoplasms | 5 | 2023 | 142 | 2.250 |
Why?
|
Echoencephalography | 7 | 2018 | 21 | 2.230 |
Why?
|
Humans | 340 | 2024 | 261506 | 2.230 |
Why?
|
Fetus | 10 | 2023 | 601 | 2.090 |
Why?
|
Eye Abnormalities | 7 | 2022 | 118 | 2.030 |
Why?
|
White Matter | 7 | 2019 | 195 | 1.980 |
Why?
|
Child Abuse | 5 | 2022 | 193 | 1.960 |
Why?
|
Diagnosis, Differential | 46 | 2022 | 4744 | 1.890 |
Why?
|
Contrast Media | 18 | 2021 | 1472 | 1.860 |
Why?
|
Spinal Injuries | 3 | 2022 | 32 | 1.730 |
Why?
|
Connectome | 5 | 2020 | 112 | 1.700 |
Why?
|
Dermoid Cyst | 5 | 2021 | 38 | 1.680 |
Why?
|
Agenesis of Corpus Callosum | 5 | 2022 | 36 | 1.630 |
Why?
|
Female | 199 | 2024 | 141928 | 1.600 |
Why?
|
Brain Neoplasms | 15 | 2023 | 4849 | 1.580 |
Why?
|
Skull | 7 | 2022 | 231 | 1.560 |
Why?
|
Ultrasonography, Prenatal | 13 | 2023 | 830 | 1.530 |
Why?
|
Skull Fractures | 5 | 2017 | 46 | 1.460 |
Why?
|
Pediatrics | 5 | 2021 | 1141 | 1.450 |
Why?
|
Neurocutaneous Syndromes | 4 | 2018 | 18 | 1.420 |
Why?
|
Male | 163 | 2022 | 123000 | 1.410 |
Why?
|
Encephalocele | 7 | 2022 | 53 | 1.380 |
Why?
|
Stroke | 12 | 2022 | 1144 | 1.360 |
Why?
|
Diffuse Axonal Injury | 4 | 2022 | 7 | 1.350 |
Why?
|
Head | 8 | 2023 | 249 | 1.310 |
Why?
|
Aicardi Syndrome | 2 | 2022 | 16 | 1.300 |
Why?
|
Adolescent | 78 | 2022 | 31252 | 1.300 |
Why?
|
Pregnancy | 38 | 2024 | 7573 | 1.280 |
Why?
|
Tuberous Sclerosis | 3 | 2019 | 136 | 1.260 |
Why?
|
Hematoma, Subdural | 4 | 2019 | 28 | 1.240 |
Why?
|
Image Interpretation, Computer-Assisted | 12 | 2019 | 592 | 1.220 |
Why?
|
Cerebral Ventricles | 7 | 2017 | 98 | 1.220 |
Why?
|
Corpus Callosum | 7 | 2022 | 138 | 1.210 |
Why?
|
Neonatal Screening | 4 | 2014 | 165 | 1.210 |
Why?
|
Vein of Galen Malformations | 2 | 2018 | 5 | 1.200 |
Why?
|
Intracranial Hemorrhages | 9 | 2015 | 121 | 1.160 |
Why?
|
Image Processing, Computer-Assisted | 16 | 2017 | 1648 | 1.120 |
Why?
|
Electric Power Supplies | 2 | 2024 | 20 | 1.090 |
Why?
|
Hypothermia, Induced | 7 | 2019 | 170 | 1.080 |
Why?
|
Scoliosis | 3 | 2017 | 139 | 1.060 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2015 | 624 | 1.040 |
Why?
|
Sensitivity and Specificity | 26 | 2022 | 4971 | 1.040 |
Why?
|
Infratentorial Neoplasms | 5 | 2020 | 45 | 1.030 |
Why?
|
Infant, Newborn, Diseases | 5 | 2018 | 186 | 1.030 |
Why?
|
Leukoencephalopathies | 2 | 2018 | 63 | 1.010 |
Why?
|
Sturge-Weber Syndrome | 3 | 2009 | 10 | 1.010 |
Why?
|
Brain Edema | 4 | 2021 | 86 | 0.980 |
Why?
|
Magnetic Resonance Angiography | 7 | 2015 | 216 | 0.970 |
Why?
|
Tuberculosis, Spinal | 1 | 2023 | 12 | 0.960 |
Why?
|
Cerebral Veins | 4 | 2021 | 28 | 0.960 |
Why?
|
Tuberculosis, Central Nervous System | 1 | 2023 | 11 | 0.960 |
Why?
|
Neck | 5 | 2018 | 383 | 0.950 |
Why?
|
Foreign Bodies | 2 | 2024 | 145 | 0.950 |
Why?
|
Retrospective Studies | 63 | 2024 | 37905 | 0.940 |
Why?
|
Neck Injuries | 2 | 2014 | 32 | 0.940 |
Why?
|
Medulloblastoma | 6 | 2020 | 540 | 0.940 |
Why?
|
Sinus Thrombosis, Intracranial | 5 | 2017 | 42 | 0.940 |
Why?
|
Tuberculosis, Meningeal | 1 | 2023 | 30 | 0.940 |
Why?
|
Central Nervous System Diseases | 4 | 2015 | 129 | 0.930 |
Why?
|
Calcinosis | 5 | 2014 | 423 | 0.920 |
Why?
|
Cerebrovascular Circulation | 7 | 2019 | 471 | 0.920 |
Why?
|
Encephalitis | 2 | 2022 | 143 | 0.910 |
Why?
|
Birth Injuries | 2 | 2014 | 24 | 0.900 |
Why?
|
Meningitis, Bacterial | 4 | 2022 | 89 | 0.890 |
Why?
|
Radiology Department, Hospital | 2 | 2020 | 52 | 0.890 |
Why?
|
Radiology | 4 | 2023 | 434 | 0.860 |
Why?
|
Cranial Fossa, Posterior | 5 | 2017 | 49 | 0.850 |
Why?
|
Cerebral Hemorrhage | 3 | 2016 | 183 | 0.850 |
Why?
|
Vena Cava, Inferior | 2 | 2020 | 190 | 0.840 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 2 | 2022 | 49 | 0.840 |
Why?
|
Pseudotumor Cerebri | 1 | 2022 | 60 | 0.830 |
Why?
|
Radiation Exposure | 1 | 2023 | 73 | 0.830 |
Why?
|
Ciliopathies | 1 | 2021 | 12 | 0.830 |
Why?
|
Cerebellar Ataxia | 1 | 2022 | 72 | 0.810 |
Why?
|
Fetoscopy | 3 | 2021 | 304 | 0.810 |
Why?
|
Postnatal Care | 2 | 2011 | 47 | 0.810 |
Why?
|
Neuromyelitis Optica | 3 | 2019 | 26 | 0.790 |
Why?
|
Anisotropy | 15 | 2019 | 181 | 0.790 |
Why?
|
Head Injuries, Closed | 3 | 2014 | 45 | 0.780 |
Why?
|
Asphyxia Neonatorum | 4 | 2019 | 15 | 0.780 |
Why?
|
Ultrasonography, Doppler, Transcranial | 3 | 2017 | 111 | 0.760 |
Why?
|
Spine | 5 | 2013 | 293 | 0.750 |
Why?
|
Brain Death | 2 | 2018 | 53 | 0.740 |
Why?
|
Scalp | 1 | 2021 | 156 | 0.730 |
Why?
|
Mitochondrial Diseases | 1 | 2022 | 137 | 0.730 |
Why?
|
Fetal Development | 1 | 2021 | 120 | 0.710 |
Why?
|
Back Pain | 3 | 2017 | 61 | 0.710 |
Why?
|
Brain Damage, Chronic | 3 | 2014 | 37 | 0.710 |
Why?
|
Astrocytoma | 5 | 2020 | 321 | 0.700 |
Why?
|
Edema | 3 | 2019 | 267 | 0.690 |
Why?
|
Cerebrovascular Disorders | 3 | 2016 | 142 | 0.690 |
Why?
|
Syringomyelia | 2 | 2016 | 18 | 0.690 |
Why?
|
Radiology Information Systems | 3 | 2020 | 114 | 0.690 |
Why?
|
Gadolinium | 4 | 2017 | 164 | 0.690 |
Why?
|
Artifacts | 4 | 2013 | 532 | 0.680 |
Why?
|
Basal Ganglia | 1 | 2019 | 64 | 0.680 |
Why?
|
Imaging, Three-Dimensional | 7 | 2015 | 925 | 0.670 |
Why?
|
Leukoaraiosis | 1 | 2018 | 6 | 0.670 |
Why?
|
Malformations of Cortical Development | 3 | 2017 | 57 | 0.660 |
Why?
|
Self-Injurious Behavior | 1 | 2019 | 54 | 0.660 |
Why?
|
Education, Medical, Graduate | 2 | 2022 | 671 | 0.640 |
Why?
|
Lipomatosis | 2 | 2015 | 24 | 0.640 |
Why?
|
Leukomalacia, Periventricular | 2 | 2015 | 13 | 0.640 |
Why?
|
Anterior Cerebral Artery | 2 | 2016 | 10 | 0.630 |
Why?
|
Retinal Hemorrhage | 2 | 2015 | 26 | 0.630 |
Why?
|
Glioblastoma | 2 | 2022 | 1797 | 0.630 |
Why?
|
Infant, Premature | 5 | 2014 | 787 | 0.630 |
Why?
|
Cerebellar Neoplasms | 4 | 2017 | 434 | 0.620 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 1 | 2017 | 10 | 0.620 |
Why?
|
Airway Obstruction | 3 | 2016 | 261 | 0.620 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2013 | 363 | 0.610 |
Why?
|
Pons | 3 | 2017 | 51 | 0.600 |
Why?
|
Spasms, Infantile | 4 | 2017 | 165 | 0.600 |
Why?
|
Diverticulum | 1 | 2017 | 35 | 0.600 |
Why?
|
Glioma | 5 | 2022 | 1963 | 0.600 |
Why?
|
Vascular Resistance | 2 | 2016 | 200 | 0.590 |
Why?
|
Neurology | 2 | 2015 | 113 | 0.580 |
Why?
|
Developmental Disabilities | 4 | 2016 | 674 | 0.580 |
Why?
|
Neurofibromatosis 1 | 3 | 2014 | 144 | 0.580 |
Why?
|
Visual Pathways | 2 | 2021 | 86 | 0.580 |
Why?
|
Connective Tissue Diseases | 1 | 2016 | 50 | 0.580 |
Why?
|
Retina | 7 | 2022 | 532 | 0.570 |
Why?
|
Bone Diseases, Developmental | 1 | 2016 | 70 | 0.570 |
Why?
|
Congenital Abnormalities | 4 | 2016 | 260 | 0.570 |
Why?
|
Geniculate Bodies | 1 | 2016 | 23 | 0.560 |
Why?
|
Spinal Cord Injuries | 2 | 2014 | 374 | 0.560 |
Why?
|
Moyamoya Disease | 2 | 2013 | 42 | 0.560 |
Why?
|
Ataxia | 6 | 2022 | 176 | 0.550 |
Why?
|
Total Quality Management | 1 | 2016 | 34 | 0.550 |
Why?
|
Musculoskeletal Abnormalities | 1 | 2016 | 82 | 0.550 |
Why?
|
Neuroradiography | 1 | 2015 | 5 | 0.550 |
Why?
|
Teratoma | 2 | 2010 | 236 | 0.540 |
Why?
|
Brain Injuries, Traumatic | 2 | 2018 | 367 | 0.540 |
Why?
|
Peritoneal Neoplasms | 2 | 2015 | 821 | 0.540 |
Why?
|
Venous Thrombosis | 2 | 2015 | 384 | 0.530 |
Why?
|
Spinal Nerve Roots | 1 | 2015 | 65 | 0.530 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2015 | 40 | 0.530 |
Why?
|
Neoplasm Seeding | 1 | 2015 | 66 | 0.530 |
Why?
|
Cerebrospinal Fluid Shunts | 2 | 2013 | 71 | 0.530 |
Why?
|
Pulmonary Valve Stenosis | 2 | 2013 | 44 | 0.520 |
Why?
|
Biomedical Research | 1 | 2022 | 806 | 0.510 |
Why?
|
Betacoronavirus | 1 | 2020 | 527 | 0.510 |
Why?
|
Hydrops Fetalis | 1 | 2015 | 66 | 0.510 |
Why?
|
Diagnostic Imaging | 5 | 2022 | 1162 | 0.500 |
Why?
|
Optic Atrophy | 2 | 2023 | 46 | 0.500 |
Why?
|
Placenta Previa | 1 | 2015 | 61 | 0.500 |
Why?
|
Visual Cortex | 1 | 2016 | 136 | 0.490 |
Why?
|
Hearing Loss, Sensorineural | 2 | 2020 | 144 | 0.490 |
Why?
|
Malignant Hyperthermia | 1 | 2014 | 23 | 0.490 |
Why?
|
Neural Tube Defects | 3 | 2024 | 341 | 0.490 |
Why?
|
Cranial Fontanelles | 1 | 2014 | 4 | 0.490 |
Why?
|
Cysts | 5 | 2017 | 197 | 0.490 |
Why?
|
Skin Abnormalities | 1 | 2014 | 23 | 0.490 |
Why?
|
Microcephaly | 4 | 2021 | 325 | 0.490 |
Why?
|
Gray Matter | 1 | 2014 | 63 | 0.490 |
Why?
|
Brain Abscess | 2 | 2012 | 60 | 0.490 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2013 | 8 | 0.480 |
Why?
|
Metabolic Diseases | 1 | 2015 | 130 | 0.480 |
Why?
|
Skull Base Neoplasms | 2 | 2022 | 314 | 0.480 |
Why?
|
Eye Diseases | 1 | 2015 | 132 | 0.480 |
Why?
|
Cardiomegaly | 1 | 2015 | 195 | 0.470 |
Why?
|
Migraine with Aura | 1 | 2013 | 17 | 0.470 |
Why?
|
Carotid Artery Injuries | 1 | 2013 | 40 | 0.470 |
Why?
|
Disability Evaluation | 2 | 2013 | 249 | 0.470 |
Why?
|
Hernia, Diaphragmatic | 1 | 2014 | 121 | 0.460 |
Why?
|
Cartilage Diseases | 1 | 2013 | 23 | 0.460 |
Why?
|
Anesthetics, Intravenous | 1 | 2013 | 73 | 0.460 |
Why?
|
Spinal Fractures | 1 | 2014 | 132 | 0.460 |
Why?
|
Hematoma, Epidural, Cranial | 2 | 2014 | 11 | 0.460 |
Why?
|
Anesthesia, General | 1 | 2015 | 239 | 0.460 |
Why?
|
Holoprosencephaly | 2 | 2012 | 21 | 0.460 |
Why?
|
Hearing Loss, Conductive | 1 | 2013 | 15 | 0.450 |
Why?
|
Propofol | 1 | 2013 | 80 | 0.450 |
Why?
|
Ear | 1 | 2013 | 38 | 0.450 |
Why?
|
Reproducibility of Results | 14 | 2021 | 6009 | 0.450 |
Why?
|
Accidental Falls | 1 | 2014 | 142 | 0.440 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2016 | 581 | 0.440 |
Why?
|
Vomiting | 1 | 2014 | 354 | 0.440 |
Why?
|
Hand Deformities, Congenital | 1 | 2013 | 87 | 0.440 |
Why?
|
Genetic Diseases, Inborn | 1 | 2016 | 442 | 0.430 |
Why?
|
Fatal Outcome | 6 | 2017 | 829 | 0.430 |
Why?
|
Hippocampus | 1 | 2018 | 915 | 0.430 |
Why?
|
Nerve Fibers | 1 | 2013 | 106 | 0.430 |
Why?
|
Central Nervous System Parasitic Infections | 1 | 2012 | 2 | 0.430 |
Why?
|
Brain Diseases, Metabolic, Inborn | 1 | 2012 | 23 | 0.430 |
Why?
|
Central Nervous System Bacterial Infections | 1 | 2012 | 6 | 0.420 |
Why?
|
Empyema, Subdural | 1 | 2012 | 9 | 0.420 |
Why?
|
Coronavirus Infections | 1 | 2020 | 651 | 0.420 |
Why?
|
Central Nervous System Fungal Infections | 1 | 2012 | 19 | 0.420 |
Why?
|
Emergencies | 2 | 2006 | 202 | 0.420 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2012 | 13 | 0.420 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 715 | 0.420 |
Why?
|
Zika Virus Infection | 3 | 2021 | 166 | 0.420 |
Why?
|
Demyelinating Diseases | 3 | 2009 | 77 | 0.410 |
Why?
|
Pandemics | 2 | 2020 | 1559 | 0.410 |
Why?
|
Wounds and Injuries | 1 | 2016 | 399 | 0.410 |
Why?
|
Tectorial Membrane | 1 | 2011 | 8 | 0.410 |
Why?
|
Brain Mapping | 4 | 2014 | 644 | 0.410 |
Why?
|
Substance-Related Disorders | 1 | 2017 | 524 | 0.410 |
Why?
|
Temporal Bone | 1 | 2013 | 102 | 0.410 |
Why?
|
Synapses | 1 | 2016 | 509 | 0.410 |
Why?
|
Infant Nutrition Disorders | 1 | 2011 | 30 | 0.410 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2015 | 393 | 0.410 |
Why?
|
Hemangioma | 2 | 2012 | 154 | 0.400 |
Why?
|
Anencephaly | 1 | 2011 | 12 | 0.400 |
Why?
|
Autopsy | 1 | 2011 | 173 | 0.390 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2009 | 122 | 0.390 |
Why?
|
Skull Base | 4 | 2024 | 199 | 0.390 |
Why?
|
Cavernous Sinus | 2 | 2017 | 33 | 0.380 |
Why?
|
Sinusitis | 3 | 2020 | 131 | 0.380 |
Why?
|
Adult | 35 | 2023 | 77950 | 0.370 |
Why?
|
Nasopharyngeal Neoplasms | 2 | 2020 | 323 | 0.370 |
Why?
|
Status Epilepticus | 1 | 2012 | 145 | 0.370 |
Why?
|
Intracranial Hypertension | 2 | 2021 | 119 | 0.360 |
Why?
|
Diagnostic Errors | 2 | 2015 | 509 | 0.360 |
Why?
|
Neoplasm Grading | 2 | 2014 | 1742 | 0.350 |
Why?
|
Multiple Sclerosis | 1 | 2013 | 349 | 0.350 |
Why?
|
Encephalomyelitis, Acute Disseminated | 2 | 2019 | 15 | 0.350 |
Why?
|
Posture | 2 | 2016 | 215 | 0.350 |
Why?
|
Abdomen | 3 | 2018 | 332 | 0.350 |
Why?
|
Twins, Conjoined | 1 | 2009 | 28 | 0.350 |
Why?
|
Homeostasis | 4 | 2016 | 950 | 0.350 |
Why?
|
Referral and Consultation | 1 | 2015 | 899 | 0.340 |
Why?
|
Nerve Degeneration | 3 | 2016 | 148 | 0.340 |
Why?
|
Mesencephalon | 1 | 2009 | 58 | 0.340 |
Why?
|
Acrocallosal Syndrome | 1 | 2008 | 1 | 0.340 |
Why?
|
Splenic Neoplasms | 1 | 2009 | 119 | 0.330 |
Why?
|
Cranial Sutures | 1 | 2008 | 31 | 0.330 |
Why?
|
Spinal Cord Diseases | 2 | 2022 | 90 | 0.330 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2017 | 787 | 0.330 |
Why?
|
Hepatoblastoma | 1 | 2011 | 215 | 0.320 |
Why?
|
Supratentorial Neoplasms | 2 | 2020 | 78 | 0.320 |
Why?
|
Liver Neoplasms | 4 | 2012 | 4557 | 0.320 |
Why?
|
Head and Neck Neoplasms | 2 | 2016 | 3976 | 0.320 |
Why?
|
Ameloblastoma | 1 | 2008 | 17 | 0.320 |
Why?
|
Tomography, Spiral Computed | 1 | 2008 | 133 | 0.310 |
Why?
|
Herniorrhaphy | 1 | 2009 | 169 | 0.310 |
Why?
|
Zika Virus | 2 | 2021 | 144 | 0.310 |
Why?
|
Ependymoma | 3 | 2019 | 242 | 0.310 |
Why?
|
Paranasal Sinuses | 2 | 2020 | 61 | 0.300 |
Why?
|
Ecchymosis | 1 | 2007 | 21 | 0.300 |
Why?
|
Syndrome | 6 | 2020 | 1351 | 0.300 |
Why?
|
Mandibular Neoplasms | 1 | 2008 | 76 | 0.300 |
Why?
|
Prognosis | 15 | 2024 | 21713 | 0.300 |
Why?
|
Arachnoid Cysts | 1 | 2007 | 12 | 0.300 |
Why?
|
Hematoma, Subdural, Acute | 1 | 2007 | 12 | 0.300 |
Why?
|
Cohort Studies | 7 | 2023 | 9244 | 0.300 |
Why?
|
Neuroblastoma | 2 | 2017 | 686 | 0.300 |
Why?
|
Cloaca | 1 | 2006 | 16 | 0.290 |
Why?
|
Osteogenesis Imperfecta | 1 | 2008 | 140 | 0.290 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2010 | 261 | 0.290 |
Why?
|
Ileal Diseases | 1 | 2006 | 27 | 0.290 |
Why?
|
Frontal Bone | 2 | 2007 | 22 | 0.280 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 2173 | 0.280 |
Why?
|
Follow-Up Studies | 19 | 2020 | 14889 | 0.280 |
Why?
|
Central Nervous System | 2 | 2023 | 436 | 0.280 |
Why?
|
Atrophy | 5 | 2018 | 261 | 0.280 |
Why?
|
Pelvis | 2 | 2018 | 362 | 0.280 |
Why?
|
Orbital Diseases | 1 | 2007 | 118 | 0.280 |
Why?
|
Young Adult | 17 | 2023 | 21445 | 0.280 |
Why?
|
Intussusception | 1 | 2006 | 52 | 0.280 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2014 | 1105 | 0.270 |
Why?
|
alpha-Fetoproteins | 2 | 2021 | 237 | 0.270 |
Why?
|
Intellectual Disability | 3 | 2023 | 1032 | 0.270 |
Why?
|
Cerebral Infarction | 2 | 2004 | 59 | 0.270 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2005 | 46 | 0.270 |
Why?
|
Meningitis, Pneumococcal | 1 | 2005 | 36 | 0.260 |
Why?
|
Gestational Age | 7 | 2021 | 1069 | 0.260 |
Why?
|
Meningomyelocele | 2 | 2021 | 183 | 0.260 |
Why?
|
Neural Pathways | 2 | 2017 | 298 | 0.260 |
Why?
|
Early Diagnosis | 4 | 2018 | 298 | 0.260 |
Why?
|
Nose Neoplasms | 2 | 2007 | 229 | 0.260 |
Why?
|
Orbital Neoplasms | 1 | 2007 | 224 | 0.260 |
Why?
|
Ocular Motility Disorders | 3 | 2014 | 47 | 0.250 |
Why?
|
Elasticity Imaging Techniques | 2 | 2017 | 171 | 0.250 |
Why?
|
Pituitary Gland | 1 | 2005 | 150 | 0.250 |
Why?
|
Oxygen | 2 | 2019 | 754 | 0.250 |
Why?
|
Globus Pallidus | 2 | 2018 | 71 | 0.250 |
Why?
|
Choriocarcinoma | 1 | 2004 | 47 | 0.250 |
Why?
|
Achondroplasia | 2 | 2014 | 21 | 0.250 |
Why?
|
Nerve Net | 2 | 2020 | 257 | 0.250 |
Why?
|
Liver Diseases | 1 | 2009 | 574 | 0.240 |
Why?
|
Hamartoma Syndrome, Multiple | 2 | 2015 | 37 | 0.240 |
Why?
|
Laser Coagulation | 1 | 2005 | 136 | 0.240 |
Why?
|
Olivary Nucleus | 2 | 2014 | 9 | 0.240 |
Why?
|
Meninges | 1 | 2023 | 47 | 0.240 |
Why?
|
Urogenital Abnormalities | 1 | 2006 | 174 | 0.240 |
Why?
|
Crohn Disease | 2 | 2015 | 351 | 0.240 |
Why?
|
Brain Stem Neoplasms | 2 | 2016 | 108 | 0.240 |
Why?
|
Severity of Illness Index | 8 | 2018 | 4320 | 0.240 |
Why?
|
Neurodevelopmental Disorders | 2 | 2020 | 413 | 0.240 |
Why?
|
Fetofetal Transfusion | 1 | 2005 | 118 | 0.230 |
Why?
|
Meningocele | 1 | 2003 | 20 | 0.230 |
Why?
|
Intracranial Pressure | 2 | 2021 | 180 | 0.230 |
Why?
|
Cerebrospinal Fluid Pressure | 1 | 2022 | 21 | 0.230 |
Why?
|
Phenotype | 3 | 2018 | 6295 | 0.220 |
Why?
|
Cervical Vertebrae | 2 | 2016 | 205 | 0.220 |
Why?
|
Aging | 1 | 2011 | 1582 | 0.220 |
Why?
|
Abdominal Injuries | 1 | 2003 | 80 | 0.220 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2007 | 489 | 0.220 |
Why?
|
Linear Models | 6 | 2016 | 1085 | 0.210 |
Why?
|
Xanthogranuloma, Juvenile | 1 | 2022 | 38 | 0.210 |
Why?
|
Heart Defects, Congenital | 1 | 2014 | 1697 | 0.210 |
Why?
|
Fourth Ventricle | 1 | 2022 | 51 | 0.210 |
Why?
|
Constriction, Pathologic | 3 | 2014 | 310 | 0.210 |
Why?
|
Spinal Cord Ischemia | 1 | 2001 | 27 | 0.210 |
Why?
|
Tinnitus | 1 | 2022 | 38 | 0.210 |
Why?
|
Glial Fibrillary Acidic Protein | 2 | 2013 | 151 | 0.200 |
Why?
|
Parotitis | 1 | 2001 | 2 | 0.200 |
Why?
|
Hyperemia | 1 | 2021 | 40 | 0.200 |
Why?
|
Wounds, Nonpenetrating | 1 | 2003 | 176 | 0.200 |
Why?
|
Career Mobility | 1 | 2022 | 95 | 0.200 |
Why?
|
Pyramidal Tracts | 2 | 2014 | 57 | 0.200 |
Why?
|
Cerebral Angiography | 3 | 2013 | 129 | 0.200 |
Why?
|
Job Satisfaction | 1 | 2022 | 122 | 0.200 |
Why?
|
Temporal Lobe | 1 | 2022 | 192 | 0.190 |
Why?
|
Placenta | 1 | 2005 | 516 | 0.190 |
Why?
|
Granuloma, Giant Cell | 1 | 2020 | 17 | 0.190 |
Why?
|
Retroperitoneal Neoplasms | 2 | 2017 | 262 | 0.190 |
Why?
|
Teleradiology | 1 | 2020 | 9 | 0.190 |
Why?
|
Organizational Objectives | 1 | 2020 | 61 | 0.190 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2000 | 18 | 0.190 |
Why?
|
Radiographic Image Enhancement | 1 | 2003 | 402 | 0.190 |
Why?
|
Radiography | 3 | 2013 | 1904 | 0.190 |
Why?
|
Burkitt Lymphoma | 1 | 2003 | 335 | 0.190 |
Why?
|
Multi-Institutional Systems | 1 | 2020 | 13 | 0.190 |
Why?
|
Pelvic Bones | 2 | 2014 | 95 | 0.190 |
Why?
|
Denosumab | 1 | 2020 | 68 | 0.180 |
Why?
|
Ganglioglioma | 1 | 2020 | 41 | 0.180 |
Why?
|
Enterocolitis, Necrotizing | 2 | 2018 | 223 | 0.180 |
Why?
|
Meningeal Neoplasms | 2 | 2017 | 441 | 0.180 |
Why?
|
Subtraction Technique | 2 | 2011 | 141 | 0.180 |
Why?
|
Nystagmus, Pathologic | 2 | 2017 | 43 | 0.180 |
Why?
|
Ear, Inner | 1 | 2020 | 57 | 0.180 |
Why?
|
Urinary Bladder | 1 | 2003 | 575 | 0.180 |
Why?
|
Computer-Aided Design | 1 | 2020 | 73 | 0.180 |
Why?
|
Personal Protective Equipment | 1 | 2020 | 64 | 0.180 |
Why?
|
Hospitals, Community | 1 | 2020 | 79 | 0.180 |
Why?
|
Workplace | 1 | 2020 | 76 | 0.180 |
Why?
|
Efficiency, Organizational | 2 | 2020 | 88 | 0.180 |
Why?
|
Rhabdoid Tumor | 1 | 2000 | 110 | 0.170 |
Why?
|
Optic Nerve Glioma | 2 | 2017 | 31 | 0.170 |
Why?
|
Models, Anatomic | 1 | 2020 | 154 | 0.170 |
Why?
|
Mediastinal Neoplasms | 1 | 2003 | 423 | 0.170 |
Why?
|
Child Health Services | 1 | 2020 | 82 | 0.170 |
Why?
|
Dilatation, Pathologic | 2 | 2010 | 88 | 0.170 |
Why?
|
Central Nervous System Infections | 1 | 1999 | 19 | 0.170 |
Why?
|
Tomography Scanners, X-Ray Computed | 2 | 2016 | 88 | 0.170 |
Why?
|
Neuroaxonal Dystrophies | 1 | 2018 | 14 | 0.170 |
Why?
|
Substantia Nigra | 1 | 2018 | 41 | 0.170 |
Why?
|
Printing, Three-Dimensional | 1 | 2020 | 129 | 0.170 |
Why?
|
Optic Nerve | 2 | 2017 | 133 | 0.170 |
Why?
|
Lyme Disease | 1 | 1999 | 34 | 0.160 |
Why?
|
Bone Density Conservation Agents | 1 | 2020 | 198 | 0.160 |
Why?
|
Evaluation Studies as Topic | 1 | 2018 | 418 | 0.160 |
Why?
|
Movement Disorders | 1 | 2021 | 232 | 0.160 |
Why?
|
Workflow | 2 | 2020 | 275 | 0.160 |
Why?
|
Artificial Intelligence | 1 | 2022 | 388 | 0.160 |
Why?
|
Seizures | 2 | 2021 | 989 | 0.160 |
Why?
|
Hernia | 2 | 2009 | 46 | 0.160 |
Why?
|
Megalencephaly | 1 | 2018 | 56 | 0.160 |
Why?
|
Glasgow Coma Scale | 3 | 2017 | 215 | 0.160 |
Why?
|
Microbubbles | 1 | 2017 | 14 | 0.150 |
Why?
|
Radiation Protection | 1 | 2019 | 205 | 0.150 |
Why?
|
Chondroma | 1 | 2017 | 31 | 0.150 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 2018 | 105 | 0.150 |
Why?
|
Reference Values | 2 | 2012 | 1099 | 0.150 |
Why?
|
Carcinoma | 1 | 2009 | 2578 | 0.150 |
Why?
|
Ischemia | 1 | 2000 | 391 | 0.150 |
Why?
|
Epilepsy | 2 | 2016 | 883 | 0.150 |
Why?
|
Discitis | 2 | 2015 | 7 | 0.150 |
Why?
|
NAV1.6 Voltage-Gated Sodium Channel | 1 | 2016 | 8 | 0.150 |
Why?
|
Hemodynamics | 3 | 2016 | 935 | 0.140 |
Why?
|
Radiation Dosage | 2 | 2019 | 1014 | 0.140 |
Why?
|
Intestine, Small | 1 | 2000 | 499 | 0.140 |
Why?
|
Thorax | 1 | 2018 | 213 | 0.140 |
Why?
|
Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 265 | 0.140 |
Why?
|
Spinal Diseases | 2 | 2013 | 125 | 0.140 |
Why?
|
Thermometry | 1 | 2015 | 8 | 0.140 |
Why?
|
Postoperative Complications | 3 | 2020 | 5542 | 0.140 |
Why?
|
Herpesvirus 4, Human | 1 | 2020 | 966 | 0.140 |
Why?
|
Hemispherectomy | 1 | 2016 | 25 | 0.140 |
Why?
|
Photons | 1 | 2019 | 507 | 0.140 |
Why?
|
Rocky Mountain Spotted Fever | 1 | 2015 | 7 | 0.140 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2000 | 384 | 0.130 |
Why?
|
Vasculitis, Central Nervous System | 1 | 2015 | 11 | 0.130 |
Why?
|
Orbit | 1 | 2017 | 205 | 0.130 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2015 | 100 | 0.130 |
Why?
|
Battered Child Syndrome | 1 | 2015 | 3 | 0.130 |
Why?
|
Body Temperature | 1 | 2015 | 158 | 0.130 |
Why?
|
Cervical Cord | 1 | 2015 | 19 | 0.130 |
Why?
|
Hospitals, Pediatric | 1 | 2020 | 773 | 0.130 |
Why?
|
Receptors, Immunologic | 1 | 2017 | 309 | 0.130 |
Why?
|
Muscular Dystrophies | 1 | 2015 | 51 | 0.130 |
Why?
|
Kidney | 1 | 2004 | 2146 | 0.130 |
Why?
|
Functional Neuroimaging | 1 | 2014 | 38 | 0.130 |
Why?
|
Otitis Media | 1 | 2015 | 65 | 0.130 |
Why?
|
Foramen Magnum | 1 | 2014 | 7 | 0.130 |
Why?
|
Uncertainty | 1 | 2017 | 320 | 0.130 |
Why?
|
Biomarkers | 4 | 2015 | 5047 | 0.130 |
Why?
|
Diabetic Ketoacidosis | 1 | 2016 | 136 | 0.130 |
Why?
|
Spectroscopy, Near-Infrared | 4 | 2018 | 173 | 0.130 |
Why?
|
Mitochondria | 1 | 2022 | 1282 | 0.130 |
Why?
|
Observer Variation | 2 | 2015 | 671 | 0.130 |
Why?
|
Oligodendroglioma | 1 | 2015 | 106 | 0.130 |
Why?
|
Spinocerebellar Tracts | 1 | 2014 | 4 | 0.120 |
Why?
|
Vascular Malformations | 1 | 2015 | 83 | 0.120 |
Why?
|
Central Nervous System Cysts | 1 | 2014 | 16 | 0.120 |
Why?
|
Age Factors | 3 | 2016 | 5377 | 0.120 |
Why?
|
Epispadias | 1 | 2014 | 3 | 0.120 |
Why?
|
Cockayne Syndrome | 1 | 2014 | 24 | 0.120 |
Why?
|
Histones | 1 | 2022 | 1466 | 0.120 |
Why?
|
Mucopolysaccharidosis I | 1 | 2013 | 7 | 0.120 |
Why?
|
Mucopolysaccharidosis II | 1 | 2013 | 11 | 0.120 |
Why?
|
Trauma, Nervous System | 1 | 2014 | 10 | 0.120 |
Why?
|
Bladder Exstrophy | 1 | 2014 | 11 | 0.120 |
Why?
|
Term Birth | 1 | 2014 | 30 | 0.120 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2016 | 419 | 0.120 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2014 | 62 | 0.120 |
Why?
|
Apraxias | 1 | 2014 | 12 | 0.120 |
Why?
|
Rubella Syndrome, Congenital | 1 | 2013 | 2 | 0.120 |
Why?
|
Leukodystrophy, Globoid Cell | 1 | 2013 | 5 | 0.120 |
Why?
|
Multidetector Computed Tomography | 1 | 2015 | 150 | 0.120 |
Why?
|
Pelvic Floor | 1 | 2014 | 48 | 0.120 |
Why?
|
Septum Pellucidum | 1 | 2013 | 11 | 0.120 |
Why?
|
Multiple Trauma | 1 | 2014 | 64 | 0.120 |
Why?
|
Resuscitation | 1 | 2016 | 223 | 0.120 |
Why?
|
Sclerotherapy | 1 | 2013 | 48 | 0.120 |
Why?
|
Periodicals as Topic | 2 | 2012 | 338 | 0.120 |
Why?
|
Hemiplegia | 1 | 2013 | 47 | 0.120 |
Why?
|
Prospective Studies | 5 | 2019 | 12873 | 0.120 |
Why?
|
Molecular Imaging | 1 | 2015 | 185 | 0.120 |
Why?
|
Monitoring, Physiologic | 1 | 2016 | 502 | 0.120 |
Why?
|
Arteriovenous Malformations | 1 | 2013 | 70 | 0.110 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2013 | 69 | 0.110 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 2013 | 47 | 0.110 |
Why?
|
Statistics, Nonparametric | 3 | 2021 | 980 | 0.110 |
Why?
|
Congenital Microtia | 1 | 2013 | 14 | 0.110 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2014 | 95 | 0.110 |
Why?
|
Immunocompromised Host | 2 | 2015 | 698 | 0.110 |
Why?
|
Meningioma | 2 | 2017 | 289 | 0.110 |
Why?
|
Subthalamic Nucleus | 1 | 2013 | 57 | 0.110 |
Why?
|
Skin | 1 | 2018 | 1259 | 0.110 |
Why?
|
Pregnancy, Twin | 1 | 2013 | 118 | 0.110 |
Why?
|
Frontal Lobe | 2 | 2014 | 187 | 0.110 |
Why?
|
Rare Diseases | 1 | 2016 | 351 | 0.110 |
Why?
|
Cranial Sinuses | 1 | 2012 | 24 | 0.110 |
Why?
|
Mutation | 4 | 2023 | 15179 | 0.110 |
Why?
|
Forecasting | 1 | 2015 | 694 | 0.110 |
Why?
|
Signal-To-Noise Ratio | 1 | 2012 | 117 | 0.110 |
Why?
|
Tegmentum Mesencephali | 1 | 2012 | 2 | 0.110 |
Why?
|
Streptococcal Infections | 1 | 2015 | 280 | 0.110 |
Why?
|
Myotonic Dystrophy | 1 | 2014 | 151 | 0.110 |
Why?
|
Orofaciodigital Syndromes | 1 | 2012 | 7 | 0.110 |
Why?
|
Infant, Low Birth Weight | 1 | 2013 | 181 | 0.110 |
Why?
|
Vigabatrin | 1 | 2012 | 15 | 0.110 |
Why?
|
Cerebral Palsy | 1 | 2013 | 63 | 0.100 |
Why?
|
Pilot Projects | 3 | 2019 | 2803 | 0.100 |
Why?
|
Brain Chemistry | 3 | 2008 | 145 | 0.100 |
Why?
|
Visual Perception | 1 | 2012 | 154 | 0.100 |
Why?
|
Radiation Injuries | 1 | 2019 | 1411 | 0.100 |
Why?
|
Knee Joint | 1 | 2012 | 161 | 0.100 |
Why?
|
Blood Flow Velocity | 1 | 2013 | 475 | 0.100 |
Why?
|
Prednisolone | 1 | 2012 | 123 | 0.100 |
Why?
|
Treatment Outcome | 9 | 2021 | 32848 | 0.100 |
Why?
|
Aorta, Abdominal | 1 | 2012 | 152 | 0.100 |
Why?
|
Medulla Oblongata | 1 | 2011 | 45 | 0.100 |
Why?
|
Academic Medical Centers | 1 | 2015 | 672 | 0.100 |
Why?
|
Feasibility Studies | 2 | 2015 | 2292 | 0.100 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2012 | 96 | 0.100 |
Why?
|
Arterial Occlusive Diseases | 1 | 2012 | 160 | 0.100 |
Why?
|
Neurologic Examination | 2 | 2014 | 245 | 0.100 |
Why?
|
Hypothermia | 1 | 2011 | 59 | 0.100 |
Why?
|
Propranolol | 1 | 2012 | 156 | 0.100 |
Why?
|
Organ Size | 2 | 2021 | 690 | 0.100 |
Why?
|
North America | 1 | 2011 | 314 | 0.100 |
Why?
|
Central Nervous System Venous Angioma | 1 | 2010 | 2 | 0.100 |
Why?
|
Predictive Value of Tests | 4 | 2018 | 4892 | 0.090 |
Why?
|
Cognition | 1 | 2017 | 968 | 0.090 |
Why?
|
Radiologists | 2 | 2022 | 163 | 0.090 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2010 | 41 | 0.090 |
Why?
|
Cerebellar Nuclei | 1 | 2010 | 13 | 0.090 |
Why?
|
Child Development | 2 | 2009 | 255 | 0.090 |
Why?
|
Diaphragmatic Eventration | 1 | 2009 | 8 | 0.090 |
Why?
|
Brain Diseases, Metabolic | 1 | 2009 | 15 | 0.090 |
Why?
|
Aortic Diseases | 1 | 2012 | 206 | 0.090 |
Why?
|
Acute Disease | 3 | 2005 | 2422 | 0.090 |
Why?
|
Infant, Premature, Diseases | 1 | 2012 | 245 | 0.090 |
Why?
|
Case-Control Studies | 6 | 2014 | 6100 | 0.090 |
Why?
|
Contraindications | 1 | 2009 | 150 | 0.090 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2012 | 323 | 0.090 |
Why?
|
Vasculitis | 1 | 2009 | 61 | 0.090 |
Why?
|
Occipital Lobe | 1 | 2009 | 48 | 0.090 |
Why?
|
Headache | 2 | 2016 | 163 | 0.090 |
Why?
|
Cystinosis | 1 | 2009 | 16 | 0.090 |
Why?
|
Parietal Lobe | 1 | 2009 | 66 | 0.090 |
Why?
|
Cerebrospinal Fluid | 1 | 2009 | 120 | 0.090 |
Why?
|
Nerve Tissue Proteins | 1 | 2017 | 1491 | 0.090 |
Why?
|
Intracranial Aneurysm | 1 | 2010 | 123 | 0.090 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 2796 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 1375 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2014 | 622 | 0.080 |
Why?
|
Preoperative Care | 1 | 2015 | 1529 | 0.080 |
Why?
|
Intelligence | 1 | 2009 | 126 | 0.080 |
Why?
|
Radiography, Panoramic | 1 | 2008 | 4 | 0.080 |
Why?
|
Anticonvulsants | 1 | 2012 | 431 | 0.080 |
Why?
|
Functional Laterality | 1 | 2009 | 316 | 0.080 |
Why?
|
Spinal Cord Compression | 1 | 2009 | 151 | 0.080 |
Why?
|
Choroid Plexus | 1 | 2007 | 31 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2012 | 629 | 0.080 |
Why?
|
Disease Progression | 3 | 2012 | 6682 | 0.080 |
Why?
|
Abortion, Induced | 1 | 2008 | 91 | 0.080 |
Why?
|
Neuropsychological Tests | 2 | 2009 | 1178 | 0.080 |
Why?
|
Psychomotor Performance | 1 | 2009 | 233 | 0.080 |
Why?
|
Nose Diseases | 1 | 2007 | 10 | 0.080 |
Why?
|
Trephining | 1 | 2007 | 1 | 0.080 |
Why?
|
Body Water | 2 | 2004 | 132 | 0.080 |
Why?
|
Premature Birth | 1 | 2012 | 407 | 0.070 |
Why?
|
Anemia, Sickle Cell | 1 | 2011 | 339 | 0.070 |
Why?
|
Rupture, Spontaneous | 1 | 2007 | 70 | 0.070 |
Why?
|
Spinal Neoplasms | 1 | 2012 | 631 | 0.070 |
Why?
|
Ileocecal Valve | 1 | 2006 | 3 | 0.070 |
Why?
|
Dominance, Cerebral | 1 | 2007 | 81 | 0.070 |
Why?
|
Subdural Effusion | 1 | 2006 | 10 | 0.070 |
Why?
|
Creatine | 1 | 2006 | 61 | 0.070 |
Why?
|
Facial Nerve Diseases | 1 | 2006 | 21 | 0.070 |
Why?
|
Pregnancy Complications | 1 | 2011 | 526 | 0.070 |
Why?
|
Choline | 1 | 2006 | 76 | 0.070 |
Why?
|
Bone Marrow Transplantation | 1 | 2011 | 1581 | 0.070 |
Why?
|
Aspartic Acid | 1 | 2006 | 126 | 0.070 |
Why?
|
Frontal Sinus | 1 | 2005 | 14 | 0.070 |
Why?
|
Oximetry | 2 | 2019 | 172 | 0.070 |
Why?
|
Recovery of Function | 1 | 2009 | 703 | 0.060 |
Why?
|
Ceftriaxone | 1 | 2005 | 67 | 0.060 |
Why?
|
Neurocognitive Disorders | 1 | 2005 | 69 | 0.060 |
Why?
|
Fetal Death | 1 | 2005 | 113 | 0.060 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2005 | 100 | 0.060 |
Why?
|
Vascular Diseases | 1 | 2007 | 246 | 0.060 |
Why?
|
Lactic Acid | 1 | 2006 | 305 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2006 | 2307 | 0.060 |
Why?
|
Supine Position | 1 | 2004 | 46 | 0.060 |
Why?
|
ROC Curve | 2 | 2014 | 1183 | 0.060 |
Why?
|
Osteomyelitis | 1 | 2007 | 236 | 0.060 |
Why?
|
Prevalence | 3 | 2019 | 3260 | 0.060 |
Why?
|
Prone Position | 1 | 2004 | 56 | 0.060 |
Why?
|
Age of Onset | 2 | 2018 | 827 | 0.060 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2005 | 165 | 0.060 |
Why?
|
Cleft Palate | 1 | 2005 | 128 | 0.060 |
Why?
|
Cerebral Cortex | 1 | 2007 | 621 | 0.060 |
Why?
|
Urography | 1 | 2003 | 43 | 0.060 |
Why?
|
Seat Belts | 1 | 2003 | 20 | 0.060 |
Why?
|
Hypertrophy | 2 | 2014 | 162 | 0.060 |
Why?
|
Exophthalmos | 1 | 2003 | 45 | 0.060 |
Why?
|
Rupture | 1 | 2003 | 61 | 0.060 |
Why?
|
Neurodegenerative Diseases | 1 | 2006 | 264 | 0.060 |
Why?
|
Postoperative Care | 2 | 2005 | 739 | 0.060 |
Why?
|
Ophthalmoplegia | 1 | 2003 | 79 | 0.060 |
Why?
|
COUP Transcription Factor I | 1 | 2023 | 81 | 0.060 |
Why?
|
Biopsy, Needle | 1 | 2007 | 1363 | 0.060 |
Why?
|
Surface Plasmon Resonance | 1 | 2022 | 105 | 0.050 |
Why?
|
Gadolinium DTPA | 1 | 2003 | 172 | 0.050 |
Why?
|
Hypertension | 1 | 2012 | 1503 | 0.050 |
Why?
|
Energy Metabolism | 1 | 2009 | 992 | 0.050 |
Why?
|
Respiratory Insufficiency | 1 | 2005 | 330 | 0.050 |
Why?
|
Diffusion | 1 | 2001 | 88 | 0.050 |
Why?
|
Perfusion | 1 | 2003 | 293 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2017 | 1945 | 0.050 |
Why?
|
Fetal Movement | 1 | 2021 | 12 | 0.050 |
Why?
|
Streptococcus agalactiae | 1 | 2022 | 107 | 0.050 |
Why?
|
Biopsy | 1 | 2009 | 3443 | 0.050 |
Why?
|
Clubfoot | 1 | 2021 | 24 | 0.050 |
Why?
|
Pulmonary Artery | 1 | 2005 | 499 | 0.050 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 543 | 0.050 |
Why?
|
Nose | 1 | 2003 | 192 | 0.050 |
Why?
|
Cerebrospinal Fluid Leak | 1 | 2021 | 54 | 0.050 |
Why?
|
Hysterotomy | 1 | 2021 | 79 | 0.050 |
Why?
|
Middle Aged | 6 | 2020 | 86204 | 0.050 |
Why?
|
Parotid Gland | 1 | 2001 | 112 | 0.050 |
Why?
|
Disposable Equipment | 1 | 2020 | 18 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 5539 | 0.050 |
Why?
|
Pregnancy Trimester, Second | 1 | 2021 | 168 | 0.050 |
Why?
|
Quarantine | 1 | 2020 | 20 | 0.050 |
Why?
|
Myoglobin | 1 | 2000 | 116 | 0.050 |
Why?
|
Muscle Hypotonia | 2 | 2012 | 180 | 0.050 |
Why?
|
Streptococcus pneumoniae | 1 | 2022 | 330 | 0.050 |
Why?
|
Blood-Brain Barrier | 1 | 2001 | 238 | 0.050 |
Why?
|
Cytogenetics | 1 | 2000 | 149 | 0.050 |
Why?
|
Embolism | 1 | 2000 | 59 | 0.050 |
Why?
|
Nasopharynx | 1 | 2020 | 119 | 0.050 |
Why?
|
Mesenteric Artery, Superior | 1 | 2000 | 71 | 0.050 |
Why?
|
Career Choice | 1 | 2022 | 232 | 0.050 |
Why?
|
Mucin-1 | 1 | 2000 | 127 | 0.040 |
Why?
|
Arabinonucleosides | 1 | 2022 | 437 | 0.040 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2000 | 169 | 0.040 |
Why?
|
Lung Diseases | 1 | 2005 | 717 | 0.040 |
Why?
|
Surveys and Questionnaires | 3 | 2022 | 5687 | 0.040 |
Why?
|
Patient Discharge | 1 | 2004 | 661 | 0.040 |
Why?
|
Maryland | 1 | 2019 | 48 | 0.040 |
Why?
|
Muscle, Smooth | 1 | 2000 | 236 | 0.040 |
Why?
|
Spin Labels | 1 | 2019 | 76 | 0.040 |
Why?
|
Colon, Sigmoid | 1 | 1999 | 42 | 0.040 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2000 | 185 | 0.040 |
Why?
|
Publishing | 1 | 2001 | 220 | 0.040 |
Why?
|
Borrelia burgdorferi Group | 1 | 1999 | 7 | 0.040 |
Why?
|
Bone Marrow | 1 | 2007 | 2358 | 0.040 |
Why?
|
Quality of Life | 2 | 2014 | 4532 | 0.040 |
Why?
|
Vimentin | 1 | 2000 | 253 | 0.040 |
Why?
|
Faculty, Medical | 1 | 2022 | 289 | 0.040 |
Why?
|
Research | 1 | 2001 | 415 | 0.040 |
Why?
|
Group VI Phospholipases A2 | 1 | 2018 | 12 | 0.040 |
Why?
|
Jugular Veins | 1 | 1999 | 107 | 0.040 |
Why?
|
Radiopharmaceuticals | 1 | 2004 | 1301 | 0.040 |
Why?
|
Motor Skills | 1 | 2019 | 107 | 0.040 |
Why?
|
Urogenital System | 1 | 2018 | 59 | 0.040 |
Why?
|
Wnt Proteins | 1 | 2020 | 397 | 0.040 |
Why?
|
Remission Induction | 1 | 2004 | 3569 | 0.040 |
Why?
|
Craniospinal Irradiation | 1 | 2019 | 128 | 0.040 |
Why?
|
Dextromethorphan | 1 | 1997 | 13 | 0.040 |
Why?
|
Necrosis | 1 | 2019 | 580 | 0.040 |
Why?
|
Hepatectomy | 1 | 2004 | 1011 | 0.040 |
Why?
|
Hedgehog Proteins | 1 | 2020 | 424 | 0.040 |
Why?
|
Family | 2 | 2014 | 736 | 0.040 |
Why?
|
Vascular Neoplasms | 1 | 2018 | 114 | 0.040 |
Why?
|
Actins | 1 | 2000 | 608 | 0.040 |
Why?
|
Retroperitoneal Space | 1 | 2017 | 145 | 0.040 |
Why?
|
Aged | 7 | 2013 | 70117 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2003 | 3981 | 0.040 |
Why?
|
Encephalitis, Tick-Borne | 1 | 1996 | 3 | 0.040 |
Why?
|
Antibodies | 1 | 2000 | 838 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2015 | 6550 | 0.040 |
Why?
|
Risk | 1 | 2021 | 1972 | 0.040 |
Why?
|
Antibodies, Bacterial | 1 | 1999 | 380 | 0.040 |
Why?
|
Life Support Systems | 1 | 2016 | 5 | 0.040 |
Why?
|
Risk Assessment | 2 | 2014 | 6869 | 0.040 |
Why?
|
Neck Pain | 1 | 2016 | 39 | 0.040 |
Why?
|
Conservative Treatment | 1 | 2016 | 58 | 0.030 |
Why?
|
Spleen | 1 | 2018 | 676 | 0.030 |
Why?
|
Escherichia coli | 1 | 2022 | 1203 | 0.030 |
Why?
|
Hypoxia | 1 | 2019 | 443 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 4314 | 0.030 |
Why?
|
Societies, Medical | 1 | 2022 | 1335 | 0.030 |
Why?
|
Immunization, Passive | 1 | 1996 | 172 | 0.030 |
Why?
|
Computed Tomography Angiography | 1 | 2017 | 234 | 0.030 |
Why?
|
Risk Factors | 2 | 2014 | 17523 | 0.030 |
Why?
|
Streptococcus anginosus | 1 | 2015 | 4 | 0.030 |
Why?
|
Learning | 1 | 2019 | 403 | 0.030 |
Why?
|
Comorbidity | 2 | 2012 | 2352 | 0.030 |
Why?
|
Logistic Models | 2 | 2014 | 3441 | 0.030 |
Why?
|
Chronic Disease | 1 | 2001 | 1819 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2007 | 8865 | 0.030 |
Why?
|
Neuroprotective Agents | 1 | 1997 | 215 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2015 | 275 | 0.030 |
Why?
|
Algorithms | 3 | 2015 | 3890 | 0.030 |
Why?
|
Optic Chiasm | 1 | 1994 | 40 | 0.030 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 1997 | 259 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2015 | 355 | 0.030 |
Why?
|
Organometallic Compounds | 1 | 2015 | 191 | 0.030 |
Why?
|
Cardiopulmonary Bypass | 1 | 1997 | 422 | 0.030 |
Why?
|
Translocation, Genetic | 1 | 2000 | 1245 | 0.030 |
Why?
|
Animals | 2 | 2014 | 59536 | 0.030 |
Why?
|
Lung | 1 | 2005 | 3151 | 0.030 |
Why?
|
Cesarean Section | 1 | 2017 | 367 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2014 | 100 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2020 | 761 | 0.030 |
Why?
|
Medical Oncology | 1 | 2022 | 1423 | 0.030 |
Why?
|
Esophagoscopy | 1 | 2015 | 291 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2015 | 173 | 0.030 |
Why?
|
Cognition Disorders | 2 | 2010 | 786 | 0.030 |
Why?
|
Likelihood Functions | 1 | 2014 | 233 | 0.030 |
Why?
|
Sclerosis | 1 | 2013 | 84 | 0.030 |
Why?
|
Steroids | 1 | 2015 | 356 | 0.030 |
Why?
|
Immunoglobulin G | 2 | 2013 | 1021 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2014 | 445 | 0.030 |
Why?
|
Angelman Syndrome | 1 | 2013 | 78 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2015 | 462 | 0.030 |
Why?
|
Sodium-Hydrogen Exchangers | 1 | 2013 | 134 | 0.030 |
Why?
|
Preoperative Period | 1 | 2014 | 344 | 0.030 |
Why?
|
Time-to-Treatment | 1 | 2015 | 292 | 0.030 |
Why?
|
HIV Infections | 1 | 2005 | 2134 | 0.030 |
Why?
|
Arterial Pressure | 1 | 2013 | 107 | 0.030 |
Why?
|
Epidural Space | 1 | 2012 | 42 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2003 | 3719 | 0.030 |
Why?
|
Recurrence | 1 | 2001 | 4758 | 0.030 |
Why?
|
Fetal Weight | 1 | 2012 | 44 | 0.030 |
Why?
|
Ischemic Attack, Transient | 1 | 2012 | 55 | 0.030 |
Why?
|
Polydactyly | 1 | 2012 | 18 | 0.030 |
Why?
|
Postoperative Period | 1 | 2014 | 665 | 0.030 |
Why?
|
Myopia | 1 | 2014 | 194 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2007 | 13658 | 0.030 |
Why?
|
Emigrants and Immigrants | 1 | 2013 | 147 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2019 | 3842 | 0.030 |
Why?
|
Immunocompetence | 1 | 2011 | 75 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2015 | 649 | 0.020 |
Why?
|
Time Factors | 1 | 2005 | 12926 | 0.020 |
Why?
|
Hemoglobins | 1 | 2013 | 477 | 0.020 |
Why?
|
Multimodal Imaging | 1 | 2015 | 550 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2016 | 609 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2004 | 4975 | 0.020 |
Why?
|
Angiography | 1 | 2012 | 360 | 0.020 |
Why?
|
Fellowships and Scholarships | 1 | 2014 | 390 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 1052 | 0.020 |
Why?
|
Karyotyping | 1 | 2012 | 1022 | 0.020 |
Why?
|
Survival Rate | 1 | 2004 | 12221 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2013 | 643 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2017 | 929 | 0.020 |
Why?
|
Wechsler Scales | 1 | 2009 | 26 | 0.020 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2011 | 273 | 0.020 |
Why?
|
Incidence | 1 | 2019 | 5673 | 0.020 |
Why?
|
Texas | 1 | 2020 | 6311 | 0.020 |
Why?
|
Psychology | 1 | 2009 | 86 | 0.020 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2011 | 388 | 0.020 |
Why?
|
Liver | 1 | 2018 | 2961 | 0.020 |
Why?
|
Blood Pressure | 1 | 2014 | 1467 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 2283 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2004 | 29902 | 0.020 |
Why?
|
Patient Safety | 1 | 2013 | 649 | 0.020 |
Why?
|
Hypertension, Renal | 1 | 2007 | 30 | 0.020 |
Why?
|
Nasal Bone | 1 | 2007 | 19 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2012 | 986 | 0.020 |
Why?
|
Respiratory Tract Fistula | 1 | 2007 | 33 | 0.020 |
Why?
|
Cutaneous Fistula | 1 | 2007 | 46 | 0.020 |
Why?
|
Cartilage | 1 | 2007 | 128 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2014 | 4298 | 0.020 |
Why?
|
United States | 2 | 2020 | 15433 | 0.020 |
Why?
|
Odds Ratio | 1 | 2011 | 2316 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 2315 | 0.020 |
Why?
|
Osteotomy | 1 | 2007 | 100 | 0.020 |
Why?
|
Echocardiography | 1 | 2011 | 1182 | 0.020 |
Why?
|
Siblings | 1 | 2007 | 285 | 0.020 |
Why?
|
Cicatrix | 1 | 2007 | 208 | 0.020 |
Why?
|
Matched-Pair Analysis | 1 | 2004 | 103 | 0.020 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2007 | 285 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2009 | 1270 | 0.010 |
Why?
|
Hypertension, Pulmonary | 1 | 2007 | 462 | 0.010 |
Why?
|
Sampling Studies | 1 | 2001 | 170 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2004 | 14289 | 0.010 |
Why?
|
Protein S Deficiency | 1 | 1999 | 2 | 0.010 |
Why?
|
Protein C Deficiency | 1 | 1999 | 12 | 0.010 |
Why?
|
Mastoid | 1 | 1999 | 26 | 0.010 |
Why?
|
Heart Failure | 1 | 2012 | 2516 | 0.010 |
Why?
|
Encephalitis Viruses, Tick-Borne | 1 | 1996 | 2 | 0.010 |
Why?
|
Spondylitis | 1 | 1996 | 7 | 0.010 |
Why?
|
Spondylolysis | 1 | 1996 | 2 | 0.010 |
Why?
|
Intervertebral Disc Displacement | 1 | 1996 | 28 | 0.010 |
Why?
|
Immunologic Tests | 1 | 1996 | 33 | 0.010 |
Why?
|
Heparin | 1 | 1999 | 360 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 1999 | 444 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 1996 | 347 | 0.010 |
Why?
|
Evoked Potentials, Visual | 1 | 1994 | 39 | 0.010 |
Why?
|
Hemianopsia | 1 | 1994 | 42 | 0.010 |
Why?
|
Visual Fields | 1 | 1994 | 142 | 0.010 |
Why?
|
Electroencephalography | 1 | 1997 | 898 | 0.010 |
Why?
|
Vision Disorders | 1 | 1994 | 245 | 0.010 |
Why?
|
Visual Acuity | 1 | 1994 | 873 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 1999 | 2992 | 0.000 |
Why?
|